Crossmark

Immune characterization of breast cancer metastases: prognostic implications

Crossref DOI link: https://doi.org/10.1186/s13058-018-1003-1

Published Online: 2018-06-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dieci, Maria Vittoria http://orcid.org/0000-0002-3967-9861
Tsvetkova, Vassilena

Orvieto, Enrico

Piacentini, Federico

Ficarra, Guido

Griguolo, Gaia

Miglietta, Federica

Giarratano, Tommaso

Omarini, Claudia

Bonaguro, Serena

Cappellesso, Rocco

Aliberti, Camillo

Vernaci, Grazia

Giorgi, Carlo Alberto

Faggioni, Giovanni

Tasca, Giulia

Conte, Pierfranco

Guarneri, Valentina
Funding

Funding for this research was provided by:

University of Padova (DOR1721185/17)

Istituto Oncologico Veneto IRCCS (L02P28)
License Information

Text and Data Mining valid from 2018-06-22
More Information

Article History

Received: 2 December 2017

Accepted: 4 June 2018

First Online: 22 June 2018

Ethics approval and consent to participate

: This research has been conducted in accordance with the Declaration of Helsinki. The study protocol has been approved by the Ethics Committee of Istituto Oncologico Veneto IRCCS of Padova and the Ethics Committee of Modena University Hospital. Patients signed the informed consent form.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.